TIGIT and CD155 as Immune-Modulator Receptor and Ligand on CD4+ T cells in Preeclampsia Patients.
Kamrani A, Soltani-Zangbar MS, Shiri S, Yousefzadeh Y, Pourakbari R, Aghebati-Maleki L, Mehdizadeh A, Danaii S, Jadidi-Niaragh F, Yousefi B, Kafil HS, Hojjat-Farsangi M, Motavalli R, Zolfaghari M, Haji-Fatahaliha M, Mahmoodpoor A, Ahmadian Heris J, Emdadi A, Yousefi M.
Kamrani A, et al. Among authors: yousefzadeh y.
Immunol Invest. 2022 May;51(4):1023-1038. doi: 10.1080/08820139.2021.1904976. Epub 2021 Apr 15.
Immunol Invest. 2022.
PMID: 33855917